Literature DB >> 7769481

The endothelium in hypertension: bystander, target or mediator?

T F Lüscher1.   

Abstract

SUBSTANCES RELEASED FROM THE ENDOTHELIUM: The endothelium has been recognized as a source of substances that affect circulating blood cells and also contractile function, migration and proliferation of vascular smooth muscle. Alterations in the release of substances such as nitric oxide, prostaglandins and endothelin-1 may not only mimic the hemodynamic alterations seen in hypertension, but may also be involved in the development of cardiovascular complications such as myocardial infarction, renal failure and stroke. ALTERATIONS IN ENDOTHELIAL FUNCTION: Alterations in endothelial function occur in experimental and human hypertension, but these changes are not uniform in different models of hypertension nor in different vascular beds. Although endothelium-dependent relaxation is generally reduced in hypertension, in particular in the cerebrovascular and renal circulation and aorta, in certain models of hypertension or vascular beds little alteration has been observed. Indeed, experimental studies suggest that most of the alterations in endothelial function in hypertension are a consequence rather than a cause of high blood pressure. This indicates that endothelial dysfunction contributes to increased peripheral vascular resistance at later stages of hypertension and most likely to the development of cardiovascular complications. Under some conditions, however, certain mediators may also be overproduced as a compensatory mechanism. EFFECT OF THERAPY ON ENDOTHELIAL DYSFUNCTION: In experimental animals, endothelial dysfunction is reversible by antihypertensive therapy. In contrast, in humans with hypertension and established endothelial dysfunction, reversal of the alterations appears more difficult.
CONCLUSIONS: The endothelium has a strategic anatomical position that allows it to regulate the function of both vascular smooth muscle and circulating blood cells (platelets, monocytes). In hypertension several alterations in endothelial function develop as the disease progresses and become most pronounced as blood pressure rises. Endothelial dysfunction may therefore make an important contribution to the pathophysiology of hypertension and its cardiovascular complications.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7769481

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


  10 in total

1.  Effect of AT1 receptor blockade on intermittent hypoxia-induced endothelial dysfunction.

Authors:  Noah J Marcus; Nathan R Philippi; Cynthia E Bird; Yu-Long Li; Harold D Schultz; Barbara J Morgan
Journal:  Respir Physiol Neurobiol       Date:  2012-06-21       Impact factor: 1.931

Review 2.  Endothelial function and the kidney. An emerging target for cardiovascular therapy.

Authors:  T J Rabelink; H A Koomans
Journal:  Drugs       Date:  1997       Impact factor: 9.546

3.  Endothelial nitric oxide synthase gene variants and primary open-angle glaucoma: interactions with hypertension, alcohol intake, and cigarette smoking.

Authors:  Jae Hee Kang; Janey L Wiggs; Bernard A Rosner; Jonathan Haines; Wael Abdrabou; Louis R Pasquale
Journal:  Arch Ophthalmol       Date:  2011-06

Review 4.  The classification of calcium antagonists and their selection in the treatment of hypertension. A reappraisal.

Authors:  T F Lüscher; F Cosentino
Journal:  Drugs       Date:  1998-04       Impact factor: 9.546

5.  Differences in acetylcholine- and bradykinin-induced vasorelaxation of the mesenteric vascular bed in spontaneously hypertensive rats of different ages.

Authors:  K J Wirth; W Linz; G Wiemer; B A Schölkens
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-06       Impact factor: 3.000

6.  Palmitoylethanolamide treatment reduces blood pressure in spontaneously hypertensive rats: involvement of cytochrome p450-derived eicosanoids and renin angiotensin system.

Authors:  Giuseppina Mattace Raso; Claudio Pirozzi; Roberta d'Emmanuele di Villa Bianca; Raffaele Simeoli; Anna Santoro; Adriano Lama; Francesca Di Guida; Roberto Russo; Carmen De Caro; Raffaella Sorrentino; Antonio Calignano; Rosaria Meli
Journal:  PLoS One       Date:  2015-05-07       Impact factor: 3.240

Review 7.  Endothelium-derived Relaxing Factors of Small Resistance Arteries in Hypertension.

Authors:  Kyu-Tae Kang
Journal:  Toxicol Res       Date:  2014-09

8.  Circulating levels of endothelin-1 in a homogenous Gulf Arab population with untreated essential hypertension.

Authors:  Enyioma Obineche; Abdishakur M Abdulle; Awais M Bokhari; Javed Y Yasin; Michael P T Gillett
Journal:  Ann Saudi Med       Date:  2006 Sep-Oct       Impact factor: 1.526

9.  Pu-Erh Tea Relaxes the Thoracic Aorta of Rats by Reducing Intracellular Calcium.

Authors:  Dan Luo; Xuejiao Chen; Xu Zhu; Shuang Liu; Jie Li; Jianping Xu; Jinhua Zhao; Xu Ji
Journal:  Front Pharmacol       Date:  2019-11-28       Impact factor: 5.810

10.  Captopril alleviates hypertension-induced renal damage, inflammation, and NF-κB activation.

Authors:  Zhongyuan Gan; Dan Huang; Jiaye Jiang; Yuan Li; Hanqing Li; Yan Ke
Journal:  Braz J Med Biol Res       Date:  2018-09-03       Impact factor: 2.590

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.